Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Hair loss gene found on chromosome 3q26.

HIV can cause unusual and severe skin problems that are hard to treat.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Itraconazole was effective in treating unusual M. canis infections in only one of two HIV-infected men.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Alopecia Areata might be linked to Crohn's disease.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

An enzyme other than TNAP might be responsible for vitamin B-6 metabolism in the skin.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.